Nabla Secures $70M Funding to Expand AI Copilot for Healthcare Professionals

Nabla's Impressive Funding Round

Nabla, a clinical AI startup, has successfully secured $70 million in Series C funding to further develop its AI copilot for healthcare professionals 1

1

2

2

. This latest investment brings the company's total funding to $120 million, with the round led by German venture capitalist firm HV Capital and participation from Highland Europe, DST Global, Cathay Innovation, and Build Collective 2

2

.

AI Copilot for Healthcare

Nabla's primary offering is an AI assistant that automates note-taking and medical report generation for doctors and other medical staff 1

1

. The company claims that its AI copilot can reduce clinical documentation time by more than half, leading to decreased clinician burnout and increased patient satisfaction 1

1

. Currently, Nabla's AI assistant is integrated into over 130 healthcare organizations, supporting more than 85,000 clinicians globally, including 20,000 in the United States 2

2

.

Rapid Growth and Market Traction

The startup has experienced significant growth in recent months, with its revenue multiplying by five over the past six months 1

1

. Nabla's AI tools now support more than 20 million annual patient encounters, with increasing adoption in rural hospitals and children's medical facilities that often face doctor shortages 2

2

.

Expansion into Agentic AI

With the new funding, Nabla plans to expand its AI capabilities beyond documentation into what it calls a "more agentic model of clinical AI" 1

1

. The company is developing an Adaptive Agentic Platform, which will include:

1. A real-time coding assistant to flag billing issues and prompt documentation during care delivery 1

   1

   2

   2

2. A context-aware agent capable of surfacing historical data and initiating actions within electronic health records 1

   1

   2

   2

3. Expanded tools for nurses and inpatient teams 1

   1

   2

   2

AI Funding Trends

Nabla's successful funding round aligns with broader trends in AI investment. Over the past year, nearly half of U.S. venture funding has gone to AI-related enterprises, with later-stage companies receiving the largest share 1

1

. Globally, AI was the leading sector for venture funding in the first quarter of the year, with $59.6 billion invested, marking the strongest quarter for AI funding ever 1

1

.

Leadership and Investor Confidence

Nabla's co-founder and CEO, Alex Lebrun, emphasized the company's vision for the future of clinical AI: "We see a future where AI not only documents care but actively drives efficiency by executing actions within complex clinical workflows and environments" 2

2

. This vision has garnered strong support from investors, with HV Capital Partner Alexander Joel-Carbonell praising Nabla's execution speed and the trust it has earned in the healthcare sector 2

2

.

Impact on Healthcare Delivery

By automating documentation and other repetitive tasks, Nabla's AI assistants aim to free up more time for healthcare professionals to focus on patient care. The company's expansion into rural hospitals and children's medical facilities highlights the potential for AI to address staffing shortages and improve healthcare delivery in underserved areas 2

2

.